A new King’s College London study finds a cancer drug may reverse brain connectivity changes linked to early Alzheimer’s ...

Researchers have dosed the first participant in a clinical trial of an investigational medicine designed to lower the amount of amyloid precursor protein (APP) for the potential treatment of Alzheimer ...

New paper from UC Santa Cruz chemistry lab argues that efforts to develop treatments for Alzheimer's should stop ignoring a short protein called P3, the ‘neglected cousin’ of amyloid beta ...

Neuroscientists at King’s College London (UK) have pinpointed a mechanism behind the increased neural connectivity seen in very early stages of Alzheimer’s disease. Published in Translational ...

Unlike treatments that focus on removing plaques that have already formed, levetiracetam works differently. It blocks the ...

Neuroscientists at King's College London have pinpointed a mechanism behind the increased neural connectivity observed in the ...

Alzheimer's disease affects millions of people around the world. To study this condition, researchers must peer inside the distinctive environment of the human brain. but for scientists to get the ...

– First Patient Dosed in Multiple-dose Part B Portion of Study, with the Study Proceeding in Canada, UK, and the Netherlands – CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq ...

Cerebrospinal fluid (CSF) is a clear and watery liquid that flows in and around the brain and spinal cord. Its functions include protecting parts of the nervous system, delivering nutrients and ...

Lactylation, a recently identified post-translational modification, has emerged as important for immune regulation, tissue repair, cancer cell metabolism, and now, potentially, Alzheimer’s disease. In ...